Biotin Anti-Human CD64 Antibody[10.1]

Biotin Anti-Human CD64 Antibody[10.1]

The Biotin Anti-Human CD64 Antibody[10.1] is a highly specific monoclonal antibody that targets the CD64 antigen, also known as FcγRI. This antigen is expressed on the surface of human monocytes, macrophages, and dendritic cells, and plays a crucial role in the immune response. The antibody is conjugated with biotin, a small molecule that allows for easy detection and purification of the target protein.

This antibody has been extensively validated for use in various applications, including flow cytometry, immunohistochemistry, and western blotting. It has been shown to specifically recognize human CD64, with no cross-reactivity with other Fcγ receptors. The antibody has also been tested for its ability to block the binding of immune complexes to CD64, making it a valuable tool for studying the role of CD64 in immune complex-mediated diseases.

The Biotin Anti-Human CD64 Antibody[10.1] is available in various sizes and formats, including purified, unconjugated, and fluorescently labeled versions. It is suitable for use in both research and diagnostic applications, and has been used in numerous studies to investigate the role of CD64 in various diseases, including autoimmune disorders, infectious diseases, and cancer. With its high specificity and versatility, this antibody is an essential tool for any researcher studying the immune system and its role in disease.